Clinical trial

Microsurgical Treatment of Breast Cancer-related Lymphedema by Lymphaticovenous…

NCT02790021 · Maastricht University Medical Center, Other · Completed

Key facts

NCT number NCT02790021
Title Microsurgical Treatment of Breast Cancer-related Lymphedema by Lymphaticovenous Anastomosis
Official title Improving the Quality of Life of Patients With Breast Cancer-related Lymphedema by Lymphaticovenous Anastomosis (LVA): A Randomized Controlled Trial
Lead sponsor Maastricht University Medical Center, Other
Collaborators ZonMw: The Netherlands Organisation for Health Research and Development
Status Completed
Study type Interventional
Conditions Lymphedema
Intervention type Procedure
Interventions Lymphaticovenous anastomosis (LVA)
Enrollment 100
Start date Jan 1, 2019
Primary completion Jan 7, 2025
Completion Jan 7, 2025
First posted Jun 3, 2016
Last update posted May 19, 2025
Countries Netherlands

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies